Medicaid hepatitis C patients more likely to be denied drug coverage

Almost half of hepatitis C patients whose doctors had prescribed antiviral drugs were denied coverage to the therapies by Medicaid because they weren't considered "a medical necessity" or because the patients tested positive for alcohol/drugs, according to a study by University of Pennsylvania researchers.

The findings are in line with a previous study, which suggested that a lack of insurance is the "only barrier" facing those unable to obtain treatment for the disease. 

Additionally, the Penn study revealed that people with hepatitis C who sought prescriptions were significantly more likely to get turned down if they had Medicaid coverage than if they were insured by Medicare or private commercial policies. Study announcement



Suggested Articles

Hospitals are already signaling a legal challenge to a final rule from CMS on price transparency, but the agency is ready.

CMS issued a proposed rule and a final rule aimed at increasing price transparency from hospitals and insurers.

Medicare Advantage insurers are eyeing loneliness as a crucial social determinant of health to target.